期刊文献+

Anti-diabetic potential of Urena lobata leaf extract through inhibition of dipeptidyl peptidase IV activity 被引量:2

Anti-diabetic potential of Urena lobata leaf extract through inhibition of dipeptidyl peptidase IV activity
下载PDF
导出
摘要 Objective: To evaluate the anti-diabetic potential of leaf extract from Urena lobata(U. lobata) through dipeptidyl peptidase IV(DPP-IV) inhibitory activity.Methods: U. lobata leaf was extracted in hot water and ethanol. The activity of DPPIV inhibitor was tested by in vitro study using gly-pro-p-nitroanilide as substrat of DPPIV and vildagliptin, as standard reference. A product of the reactions between gly-pro-pnitroanilide and DPP-IV, was observed by microplate readers with λ = 405 nm. All data were expressed as mean ± SD and the IC50 value was determined by non linear regression curve fit. Active substances in leaf extract of U. lobata was analyzed by liquid chromatography-mass spectrometry. DPP-IV inhibitory activity of active compounds was evaluated in silico using docking server. Results: The ethanolic extract of U. lobata showed stronger DPP-IV inhibitor activity than water extract with the IC50 values of 1 654.64 and 6 489.88 μg/mL, respectively. Vildagliptin, based on standard reference for DPP-IV inhibitor activity, has IC50 value of 57.44 μg/mL. Based on in silico analysis, mangiferin, stigmasterol and β-sitosterol in U. lobata extract have a strong inhibitory activity on DPP-IV. Conclusions: The results showed that DPP-IV inhibitory activity of U. lobata is related to its active compounds such as mangiferin, stigmasterol and β-sitosterol. Objective: To evaluate the anti-diabetic potential of leaf extract from Urena lobata(U. lobata) through dipeptidyl peptidase IV(DPP-IV) inhibitory activity.Methods: U. lobata leaf was extracted in hot water and ethanol. The activity of DPPIV inhibitor was tested by in vitro study using gly-pro-p-nitroanilide as substrat of DPPIV and vildagliptin, as standard reference. A product of the reactions between gly-pro-pnitroanilide and DPP-IV, was observed by microplate readers with λ = 405 nm. All data were expressed as mean ± SD and the IC50 value was determined by non linear regression curve fit. Active substances in leaf extract of U. lobata was analyzed by liquid chromatography-mass spectrometry. DPP-IV inhibitory activity of active compounds was evaluated in silico using docking server. Results: The ethanolic extract of U. lobata showed stronger DPP-IV inhibitor activity than water extract with the IC50 values of 1 654.64 and 6 489.88 μg/mL, respectively. Vildagliptin, based on standard reference for DPP-IV inhibitor activity, has IC50 value of 57.44 μg/mL. Based on in silico analysis, mangiferin, stigmasterol and β-sitosterol in U. lobata extract have a strong inhibitory activity on DPP-IV. Conclusions: The results showed that DPP-IV inhibitory activity of U. lobata is related to its active compounds such as mangiferin, stigmasterol and β-sitosterol.
出处 《Asian Pacific Journal of Tropical Biomedicine》 SCIE CAS 2015年第8期630-634,共5页 亚太热带生物医学杂志(英文版)
基金 Supported by a grant of doctoral dissertation research from Education Ministry of Indonesia
关键词 ANTI-DIABETIC Dipeptidyl PEPTIDASE IV In silico In VITRO Urena lobata Anti-diabetic Dipeptidyl peptidase IV In silico In vitro Urena lobata
  • 相关文献

参考文献14

  • 1Seema Patel.Pumpkin ( Cucurbita sp.) seeds as nutraceutic: a review on status quo and scopes[J]. Mediterranean Journal of Nutrition and Metabolism . 2013 (3)
  • 2Jing-Hsien Chen,Chia-Wen Tsai,Chi-Ping Wang,Hui-Hsuan Lin.Anti-atherosclerotic potential of gossypetin via inhibiting LDL oxidation and foam cell formation[J]. Toxicology and Applied Pharmacology . 2013
  • 3Cicero L. T. Chang,Yenshou Lin,Arlene P. Bartolome,Yi-Ching Chen,Shao-Chih Chiu,Wen-Chin Yang,William C. Cho.Herbal Therapies for Type 2 Diabetes Mellitus: Chemistry, Biology, and Potential Application of Selected Plants and Compounds[J]. Evidence-Based Complementary and Alternative Medicine . 2013
  • 4S. Panda,M. Jafri,A. Kar,B.K. Meheta.Thyroid inhibitory, antiperoxidative and hypoglycemic effects of stigmasterol isolated from Butea monosperma[J]. Fitoterapia . 2008 (2)
  • 5Onoagbe IO,Negbenebor EO,Ogbeide VO,Dawha IH,Attah V,Lau HU,et al.A study of the anti-diabetic effects of Urena lobata and Sphenostylis stenocarpa in streptozotocin-induced diabetic rats. Eur J Sci Res . 2010
  • 6GOPALAN B,RAVI D,RASHEED M,et al.Novel dipeptidyl peptidase IV inhibitors and processes for their preparation and pharmaceutical compositions containing them. WO,2007113634 . 2007
  • 7Wang Y,Li L,Yang M,Liu H,Boden G,Yang G.Glucagon-like peptide-1 receptor agonists versus insulin in inadequately controlled patients with type 2 diabetes mellitus: a meta-analysis of clinical trials. Diabetes Obesity and Metabolism . 2011
  • 8Duez Hélène,Smith Angela C,Xiao C,Giacca Adria,Szeto Linda,Drucker Daniel J,Lewis Gary F.Acute dipeptidyl peptidase-4 inhibition rapidly enhances insulin-mediated suppression of endogenous glucose production in mice. The Journal of Endocrinology . 2008
  • 9Chahar Maheep K,Sharma Neelu,Dobhal Mahabeer P,Joshi Yogesh C.Flavonoids: A versatile source of anticancer drugs. Pharmacognosy reviews . 2011
  • 10Utomo Didik H,Widodo Nashi,Rifa’i M.Identifications small molecules inhibitor of p53-mortalin complex for cancer drug using virtual screening. BioInformation . 2012

共引文献1

同被引文献19

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部